Compugen Ltd.
CGEN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $28 | $33 | $8 | $6 |
| % Growth | -16.7% | 346.1% | 25% | – |
| Cost of Goods Sold | $8 | $2 | $1 | $1 |
| Gross Profit | $20 | $31 | $7 | $5 |
| % Margin | 71.5% | 94% | 87% | 88.7% |
| R&D Expenses | $25 | $34 | $31 | $29 |
| G&A Expenses | $9 | $10 | $10 | $11 |
| SG&A Expenses | $10 | $10 | $11 | $12 |
| Sales & Mktg Exp. | $1 | $0 | $1 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $35 | $44 | $42 | $40 |
| Operating Income | -$15 | -$13 | -$35 | -$35 |
| % Margin | -53.4% | -38.8% | -471.7% | -584.6% |
| Other Income/Exp. Net | $5 | $3 | $2 | $1 |
| Pre-Tax Income | -$10 | -$10 | -$34 | -$34 |
| Tax Expense | $5 | $9 | $0 | $0 |
| Net Income | -$14 | -$19 | -$34 | -$34 |
| % Margin | -51.1% | -56.1% | -449.3% | -570.1% |
| EPS | -0.16 | -0.21 | -0.39 | -0.41 |
| % Growth | 23.8% | 46.2% | 4.9% | – |
| EPS Diluted | -0.16 | -0.21 | -0.39 | -0.41 |
| Weighted Avg Shares Out | 90 | 88 | 87 | 84 |
| Weighted Avg Shares Out Dil | 90 | 88 | 87 | 84 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5 | $3 | $1 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$14 | -$13 | -$33 | -$35 |
| % Margin | -51.7% | -37.4% | -441.7% | -576.9% |